Effect of individualized homeopathic medicines in cases of atopic dermatitis in age group 10 to 35 years with SCORAD assessment - A case study design.

This clinical study assesses the efficacy of individualized homeopathic medicines in managing atopic dermatitis (AD) among 50 patients aged 10–35 years, using the validated SCORAD (Scoring Atopic Dermatitis) tool. Conducted over 4 years, the single-arm case study design excludes severe cases (SCORAD >70%), comorbidities, or long-term steroid users. Participants receive remedies tailored to symptom totality (itch, redness, oozing, lichenification, sleep loss), with plain coconut oil as the sole adjunct. SCORAD scores—evaluating lesion extent, intensity, and subjective symptoms—are measured at baseline and monthly follow-ups until remission. Statistical analysis (paired t-tests/Wilcoxon tests) will determine significance (p<0.05) in score reduction. Secondary objectives include analyzing frequently prescribed remedies (e.g., *Sulphur*, *Graphites*) and symptom patterns. The study addresses a critical evidence gap, as prior homeopathic AD trials involved small cohorts. By demonstrating non-invasive, personalized treatment potential, it aims to reduce reliance on conventional therapies (corticosteroids/immunosuppressants) and improve quality of life. Ethical approval and informed consent are secured, with vernacular (Marathi) documents ensuring participant accessibility. Outcomes may inform integrative dermatology protocols in India’s high-AD-burden setting.